Citadel Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-900
| Closed | -$864 | – | 15577 |
|
|
2023
Q2 | $864 | Sell |
900
-1,900
| -68% | -$1.88K | ﹤0.01% | 14034 |
|
|
2023
Q1 | $2.1K | Sell |
2,800
-12,100
| -81% | -$8.83K | ﹤0.01% | 14202 |
|
|
2022
Q4 | $5.49K | Sell |
14,900
-48,700
| -77% | -$20.5K | ﹤0.01% | 13991 |
|
|
2022
Q3 | $27K | Buy |
+63,600
| New | +$62.5K | ﹤0.01% | 11964 |
|
|
2022
Q2 | – | Sell |
-29,800
| Closed | -$38K | – | 14561 |
|
|
2022
Q1 | $38K | Sell |
29,800
-36,300
| -55% | -$33.4K | ﹤0.01% | 12977 |
|
|
2021
Q4 | $84K | Sell |
66,100
-39,100
| -37% | -$69.9K | ﹤0.01% | 12899 |
|
|
2021
Q3 | $229K | Sell |
105,200
-62,400
| -37% | -$170K | ﹤0.01% | 11688 |
|
|
2021
Q2 | $629K | Buy |
167,600
+65,400
| +64% | +$227K | ﹤0.01% | 9504 |
|
|
2021
Q1 | $333K | Buy |
102,200
+66,700
| +188% | +$239K | ﹤0.01% | 10598 |
|
|
2020
Q4 | $121K | Sell |
35,500
-7,100
| -17% | -$29.2K | ﹤0.01% | 10097 |
|
|
2020
Q3 | $174K | Buy |
42,600
+16,400
| +63% | +$62.4K | ﹤0.01% | 8917 |
|
|
2020
Q2 | $89K | Sell |
26,200
-11,700
| -31% | -$34.1K | ﹤0.01% | 9061 |
|
|
2020
Q1 | $88K | Sell |
37,900
-112,500
| -75% | -$308K | ﹤0.01% | 8711 |
|
|
2019
Q4 | $547K | Buy |
150,400
+118,600
| +373% | +$958K | ﹤0.01% | 6669 |
|
|
2019
Q3 | $264K | Buy |
+31,800
| New | +$257K | ﹤0.01% | 7755 |
|
|
2019
Q2 | – | Sell |
-27,300
| Closed | -$292K | – | 10052 |
|
|
2019
Q1 | $292K | Sell |
27,300
-13,200
| -33% | -$141K | ﹤0.01% | 7658 |
|
|
2018
Q4 | $354K | Sell |
40,500
-64,400
| -61% | -$820K | ﹤0.01% | 6979 |
|
|
2018
Q3 | $1.76M | Buy |
104,900
+56,200
| +115% | +$1.22M | ﹤0.01% | 4617 |
|
|
2018
Q2 | $1.02M | Sell |
48,700
-300
| -0.6% | -$5.56K | ﹤0.01% | 5179 |
|
|
2018
Q1 | $788K | Buy |
49,000
+15,100
| +45% | +$299K | ﹤0.01% | 5165 |
|
|
2017
Q4 | $642K | Buy |
+33,900
| New | +$614K | ﹤0.01% | 5301 |
|
|
2016
Q1 | – | Sell |
-3,100
| Closed | -$19K | – | 8270 |
|
|
2015
Q4 | $19K | Sell |
3,100
-100
| -3% | -$572 | ﹤0.01% | 7979 |
|
|
2015
Q3 | $19K | Sell |
3,200
-1,500
| -32% | -$10.4K | ﹤0.01% | 8204 |
|
|
2015
Q2 | $32K | Sell |
4,700
-9,300
| -66% | -$59K | ﹤0.01% | 7921 |
|
|
2015
Q1 | $85K | Buy |
14,000
+500
| +4% | +$3.33K | ﹤0.01% | 6980 |
|
|
2014
Q4 | $94K | Sell |
13,500
-4,100
| -23% | -$30.1K | ﹤0.01% | 6692 |
|
|
2014
Q3 | $143K | Sell |
17,600
-1,500
| -8% | -$11.7K | ﹤0.01% | 6062 |
|
|
2014
Q2 | $155K | Sell |
19,100
-5,000
| -21% | -$37.9K | ﹤0.01% | 5839 |
|
|
2014
Q1 | $189K | Buy |
24,100
+15,500
| +180% | +$131K | ﹤0.01% | 5568 |
|
|
2013
Q4 | $76K | Sell |
8,600
-3,300
| -28% | -$29.5K | ﹤0.01% | 5807 |
|
|
2013
Q3 | $100K | Sell |
11,900
-24,300
| -67% | -$197K | ﹤0.01% | 5343 |
|
|
2013
Q2 | $270K | Buy |
+36,200
| New | +$278K | ﹤0.01% | 4392 |
|
Citadel Advisors's SPPI Position: Q3 2023 in Review
Citadel Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 100 shares — an estimated $96 sold.
Citadel Advisors first reported a position in SPPI in Q2 2013 and held it in 35 quarters. The position peaked at $26.5M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Citadel Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Citadel Advisors sold 100 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $96.
- Citadel Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Citadel Advisors's Spectrum Pharmaceuticals Inc position peaked at $26.5M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.